| Date |
Report No. |
Title |
| Date Sept. 23, 2011 |
Report No. GAO-11-836 |
Title
United States Government Accountability Office GAO
September 2011 Report to Congressional Committees DRUG PRICING Manufacturer Discounts in the 340B Program Offer Benefits, but Federal Oversight Needs Improvement GAO-11-836 September 2011 DRUG PRICING
Manufacturer Discounts in the 340B Program Offer Benefits, but Federal Oversight Needs Improvement
Highlights of GAO-11-836, a report to congression... |
| Date Feb. 9, 2007 |
Report No. GAO-07-481T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:00 a.m. EST Friday, February 9, 2007 Testimony Before the Committee on Oversight and Government Reform, House of Representatives PRESCRIPTION DRUGS Oversight of Drug Pricing in Federal Programs
Statement of John E. Dicken Director, Health Care GAO-07-481T February 9, 2007 PRESCRIPTION DRUGS Highlights
Highlig... |
| Date April 26, 2006 |
Report No. GAO-06-646 |
Title
United States Government Accountability Office GAO
April 2006 Report to Congressional Requesters RYAN WHITE CARE ACT Improved Oversight Needed to Ensure AIDS Drug Assistance Programs Obtain Best Prices for Drugs GAO-06-646 April 2006 RYAN WHITE CARE ACT Highlights
Highlights of GAO-06-646, a report to congressional requesters Accountability Integrity Reliability Improved Oversight Needed to Ensure... |
